Thelansis

  Relapses, which are episodic exacerbations of neurological signs or symptoms, constitute a defining aspect of relapsing-remitting multiple sclerosis (MS), the most prevalent phenotype within the spectrum of MS. These relapses primarily contribute to the diagnostic criteria for clinically definite MS, while their prognostic significance stems from their tendency to result in incomplete remission and subsequent residual disability. Although the underlying mechanisms governing the occurrence of relapses remain unidentified, a range of factors that modify the risk of relapse has been identified. These factors encompass demographic and clinical attributes, many of which offer opportunities for enhancing disease management. Furthermore, the specific patterns of relapse have been linked to patient and disease characteristics, suggesting that a person's predisposition to certain phenotypic manifestations might indicate distinct neuroanatomical disease patterns. Immunomodulatory therapi...

 Relapses, which are episodic exacerbations of neurological signs or symptoms, constitute a defining aspect of relapsing-remitting multiple sclerosis (MS), the most prevalent phenotype within the spectrum of MS. These relapses primarily contribute to the diagnostic criteria for clinically definite MS, while their prognostic significance stems from their tendency to result in incomplete remission and subsequent residual disability. Although the underlying mechanisms governing the occurrence of relapses remain unidentified, a range of factors that modify the risk of relapse has been identified. These factors encompass demographic and clinical attributes, many of which offer opportunities for enhancing disease management. Furthermore, the specific patterns of relapse have been linked to patient and disease characteristics, suggesting that a person's predisposition to certain phenotypic manifestations might indicate distinct neuroanatomical disease patterns. Immunomodulatory therapies ...

  Relapses, which are episodic exacerbations of neurological signs or symptoms, constitute a defining aspect of relapsing-remitting multiple sclerosis (MS), the most prevalent phenotype within the spectrum of MS. These relapses primarily contribute to the diagnostic criteria for clinically definite MS, while their prognostic significance stems from their tendency to result in incomplete remission and subsequent residual disability. Although the underlying mechanisms governing the occurrence of relapses remain unidentified, a range of factors that modify the risk of relapse has been identified. These factors encompass demographic and clinical attributes, many of which offer opportunities for enhancing disease management. Furthermore, the specific patterns of relapse have been linked to patient and disease characteristics, suggesting that a person's predisposition to certain phenotypic manifestations might indicate distinct neuroanatomical disease patterns. Immunomodulatory therapi...